| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP:ADP antiporter activity | 1.38e-07 | 5 | 49 | 3 | GO:0005471 | |
| GeneOntologyMolecularFunction | ADP transmembrane transporter activity | 2.26e-06 | 11 | 49 | 3 | GO:0015217 | |
| GeneOntologyMolecularFunction | ATP transmembrane transporter activity | 4.96e-06 | 14 | 49 | 3 | GO:0005347 | |
| GeneOntologyMolecularFunction | purine ribonucleotide transmembrane transporter activity | 2.38e-05 | 23 | 49 | 3 | GO:0005346 | |
| GeneOntologyMolecularFunction | adenine nucleotide transmembrane transporter activity | 3.47e-05 | 26 | 49 | 3 | GO:0000295 | |
| GeneOntologyMolecularFunction | purine nucleotide transmembrane transporter activity | 4.85e-05 | 29 | 49 | 3 | GO:0015216 | |
| GeneOntologyMolecularFunction | oxidative phosphorylation uncoupler activity | 5.87e-05 | 5 | 49 | 2 | GO:0017077 | |
| GeneOntologyMolecularFunction | adenine transmembrane transporter activity | 5.87e-05 | 5 | 49 | 2 | GO:0015207 | |
| GeneOntologyMolecularFunction | nucleotide transmembrane transporter activity | 7.19e-05 | 33 | 49 | 3 | GO:0015215 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 7.80e-05 | 293 | 49 | 6 | GO:0008514 | |
| GeneOntologyMolecularFunction | organophosphate ester transmembrane transporter activity | 1.19e-04 | 39 | 49 | 3 | GO:0015605 | |
| GeneOntologyMolecularFunction | purine nucleobase transmembrane transporter activity | 2.62e-04 | 10 | 49 | 2 | GO:0005345 | |
| GeneOntologyMolecularFunction | sodium channel activity | 2.82e-04 | 52 | 49 | 3 | GO:0005272 | |
| GeneOntologyMolecularFunction | nucleobase transmembrane transporter activity | 3.20e-04 | 11 | 49 | 2 | GO:0015205 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 4.10e-04 | 59 | 49 | 3 | GO:1901505 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 4.10e-04 | 59 | 49 | 3 | GO:0015932 | |
| GeneOntologyMolecularFunction | sodium ion binding | 5.27e-04 | 14 | 49 | 2 | GO:0031402 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 8.15e-04 | 171 | 49 | 4 | GO:0015081 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 1.85e-03 | 26 | 49 | 2 | GO:0005248 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 1.85e-03 | 26 | 49 | 2 | GO:0031420 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SFXN1 SLC17A2 ABCC1 SLC25A4 SLC25A5 SLC25A6 SCN2A SCN8A GRIK3 | 2.05e-03 | 1180 | 49 | 9 | GO:0022857 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 2.37e-03 | 758 | 49 | 7 | GO:0015318 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 2.74e-03 | 238 | 49 | 4 | GO:0016747 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 3.04e-03 | 793 | 49 | 7 | GO:0015075 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 3.72e-03 | 37 | 49 | 2 | GO:0004190 | |
| GeneOntologyMolecularFunction | transporter activity | SFXN1 SLC17A2 ABCC1 SLC25A4 SLC25A5 SLC25A6 SCN2A SCN8A GRIK3 | 3.73e-03 | 1289 | 49 | 9 | GO:0005215 |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 3.92e-03 | 38 | 49 | 2 | GO:0070001 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 4.15e-03 | 627 | 49 | 6 | GO:0022890 | |
| GeneOntologyMolecularFunction | antiporter activity | 4.72e-03 | 138 | 49 | 3 | GO:0015297 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 4.82e-03 | 279 | 49 | 4 | GO:0005096 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 5.48e-03 | 664 | 49 | 6 | GO:0008324 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 5.94e-03 | 296 | 49 | 4 | GO:0015291 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 6.12e-03 | 477 | 49 | 5 | GO:0022804 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 7.87e-03 | 507 | 49 | 5 | GO:0060589 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 7.87e-03 | 507 | 49 | 5 | GO:0030695 | |
| GeneOntologyBiologicalProcess | mitochondrial ADP transmembrane transport | 1.18e-07 | 5 | 48 | 3 | GO:0140021 | |
| GeneOntologyBiologicalProcess | mitochondrial ATP transmembrane transport | 6.57e-07 | 8 | 48 | 3 | GO:1990544 | |
| GeneOntologyBiologicalProcess | ADP transport | 2.56e-06 | 12 | 48 | 3 | GO:0015866 | |
| GeneOntologyBiologicalProcess | regulation of mitochondrial membrane permeability involved in apoptotic process | 5.06e-06 | 49 | 48 | 4 | GO:1902108 | |
| GeneOntologyBiologicalProcess | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 5.28e-06 | 15 | 48 | 3 | GO:1901029 | |
| GeneOntologyBiologicalProcess | nucleotide transport | 5.49e-06 | 50 | 48 | 4 | GO:0006862 | |
| GeneOntologyBiologicalProcess | regulation of mitochondrial membrane permeability | 1.67e-05 | 66 | 48 | 4 | GO:0046902 | |
| GeneOntologyBiologicalProcess | negative regulation of mitochondrial membrane permeability | 2.03e-05 | 23 | 48 | 3 | GO:0035795 | |
| GeneOntologyBiologicalProcess | ATP transport | 2.03e-05 | 23 | 48 | 3 | GO:0015867 | |
| GeneOntologyBiologicalProcess | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.31e-05 | 24 | 48 | 3 | GO:1901028 | |
| GeneOntologyBiologicalProcess | negative regulation of membrane permeability | 2.96e-05 | 26 | 48 | 3 | GO:1905709 | |
| GeneOntologyBiologicalProcess | regulation of membrane permeability | 4.14e-05 | 83 | 48 | 4 | GO:0090559 | |
| GeneOntologyBiologicalProcess | nucleotide transmembrane transport | 5.08e-05 | 31 | 48 | 3 | GO:1901679 | |
| GeneOntologyBiologicalProcess | mitochondrial outer membrane permeabilization | 6.14e-05 | 33 | 48 | 3 | GO:0097345 | |
| GeneOntologyBiologicalProcess | adenine transport | 7.91e-05 | 6 | 48 | 2 | GO:0015853 | |
| GeneOntologyBiologicalProcess | mitochondrial transmembrane transport | 1.08e-04 | 106 | 48 | 4 | GO:1990542 | |
| GeneOntologyBiologicalProcess | purine-containing compound transmembrane transport | 1.10e-04 | 40 | 48 | 3 | GO:0072530 | |
| GeneOntologyBiologicalProcess | positive regulation of mitochondrial membrane permeability involved in apoptotic process | 1.10e-04 | 40 | 48 | 3 | GO:1902110 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide transport | 1.10e-04 | 40 | 48 | 3 | GO:0015868 | |
| GeneOntologyBiologicalProcess | mitochondrial transport | 1.12e-04 | 205 | 48 | 5 | GO:0006839 | |
| GeneOntologyBiologicalProcess | mitochondrial outer membrane permeabilization involved in programmed cell death | 1.27e-04 | 42 | 48 | 3 | GO:1902686 | |
| GeneOntologyBiologicalProcess | adenine nucleotide transport | 1.27e-04 | 42 | 48 | 3 | GO:0051503 | |
| GeneOntologyBiologicalProcess | purine nucleotide transport | 1.46e-04 | 44 | 48 | 3 | GO:0015865 | |
| GeneOntologyBiologicalProcess | positive regulation of mitochondrial membrane permeability | 1.57e-04 | 45 | 48 | 3 | GO:0035794 | |
| GeneOntologyBiologicalProcess | organic anion transport | 1.76e-04 | 515 | 48 | 7 | GO:0015711 | |
| GeneOntologyBiologicalProcess | positive regulation of membrane permeability | 2.15e-04 | 50 | 48 | 3 | GO:1905710 | |
| GeneOntologyBiologicalProcess | apoptotic mitochondrial changes | 2.30e-04 | 129 | 48 | 4 | GO:0008637 | |
| GeneOntologyBiologicalProcess | regulation of apoptotic cell clearance | 2.36e-04 | 10 | 48 | 2 | GO:2000425 | |
| GeneOntologyBiologicalProcess | mitochondrial membrane organization | 2.44e-04 | 131 | 48 | 4 | GO:0007006 | |
| GeneOntologyBiologicalProcess | purine nucleobase transport | 3.45e-04 | 12 | 48 | 2 | GO:0006863 | |
| GeneOntologyBiologicalProcess | nucleobase transport | 4.07e-04 | 13 | 48 | 2 | GO:0015851 | |
| GeneOntologyBiologicalProcess | organophosphate ester transport | 5.45e-04 | 162 | 48 | 4 | GO:0015748 | |
| GeneOntologyBiologicalProcess | positive regulation of mitophagy | 6.23e-04 | 16 | 48 | 2 | GO:1901526 | |
| GeneOntologyBiologicalProcess | positive regulation of autophagy of mitochondrion | 8.84e-04 | 19 | 48 | 2 | GO:1903599 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | 9.49e-04 | 1115 | 48 | 9 | GO:0034220 | |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | 1.06e-03 | 335 | 48 | 5 | GO:0043087 | |
| GeneOntologyBiologicalProcess | membrane organization | 1.12e-03 | 914 | 48 | 8 | GO:0061024 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative transport | 1.45e-03 | 96 | 48 | 3 | GO:1901264 | |
| GeneOntologyCellularComponent | sodium channel complex | 3.74e-05 | 29 | 47 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | mitochondrial permeability transition pore complex | 1.03e-04 | 7 | 47 | 2 | GO:0005757 | |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 3.80e-04 | 13 | 47 | 2 | GO:1990907 | |
| GeneOntologyCellularComponent | presynaptic membrane | 3.83e-04 | 277 | 47 | 5 | GO:0042734 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 6.59e-04 | 17 | 47 | 2 | GO:0001518 | |
| GeneOntologyCellularComponent | node of Ranvier | 9.16e-04 | 20 | 47 | 2 | GO:0033268 | |
| HumanPheno | Neonatal electro-clinical non-motor seizure | 1.15e-05 | 5 | 6 | 2 | HP:0032812 | |
| HumanPheno | Neonatal seizure with electrographic correlate | 1.15e-05 | 5 | 6 | 2 | HP:0032808 | |
| HumanPheno | Neonatal electro-clinical seizure | 1.15e-05 | 5 | 6 | 2 | HP:0032809 | |
| HumanPheno | Neonatal electro-clinical seizure with behavior arrest | 1.15e-05 | 5 | 6 | 2 | HP:0032823 | |
| HumanPheno | Focal head nodding automatism seizure | 1.15e-05 | 5 | 6 | 2 | HP:0032906 | |
| HumanPheno | Normal interictal EEG | 1.73e-05 | 6 | 6 | 2 | HP:0002372 | |
| HumanPheno | Eyelid myoclonia seizure | 2.42e-05 | 7 | 6 | 2 | HP:0032678 | |
| HumanPheno | Neonatal seizure | 6.33e-05 | 11 | 6 | 2 | HP:0032807 | |
| HumanPheno | Focal automatism seizure | 7.59e-05 | 12 | 6 | 2 | HP:0032898 | |
| HumanPheno | Complex febrile seizure | 1.38e-04 | 16 | 6 | 2 | HP:0011172 | |
| HumanPheno | Psychomotor deterioration | 2.18e-04 | 20 | 6 | 2 | HP:0002361 | |
| HumanPheno | Focal tonic seizure | 2.89e-04 | 23 | 6 | 2 | HP:0011167 | |
| HumanPheno | Focal hemiclonic seizure | 3.43e-04 | 25 | 6 | 2 | HP:0006813 | |
| HumanPheno | Simple febrile seizure | 4.01e-04 | 27 | 6 | 2 | HP:0011171 | |
| HumanPheno | Limb myoclonus | 4.63e-04 | 29 | 6 | 2 | HP:0045084 | |
| HumanPheno | Cogwheel rigidity | 5.65e-04 | 32 | 6 | 2 | HP:0002396 | |
| HumanPheno | Generalized clonic seizure | 6.38e-04 | 34 | 6 | 2 | HP:0011169 | |
| HumanPheno | Focal non-motor seizure | 8.84e-04 | 40 | 6 | 2 | HP:0032679 | |
| HumanPheno | Cerebellar atrophy | 9.08e-04 | 468 | 6 | 4 | HP:0001272 | |
| HumanPheno | Atrophy/Degeneration affecting the cerebellum | 9.23e-04 | 470 | 6 | 4 | HP:0007368 | |
| HumanPheno | Focal clonic seizure | 9.75e-04 | 42 | 6 | 2 | HP:0002266 | |
| HumanPheno | Rigidity | 1.33e-03 | 214 | 6 | 3 | HP:0002063 | |
| HumanPheno | Bilateral tonic-clonic seizure with focal onset | 1.49e-03 | 52 | 6 | 2 | HP:0007334 | |
| Domain | Mit_uncoupling | 3.45e-06 | 12 | 48 | 3 | IPR002030 | |
| Domain | BCL9_beta-catenin-bd_dom | 6.47e-06 | 2 | 48 | 2 | IPR024670 | |
| Domain | BCL9 | 6.47e-06 | 2 | 48 | 2 | PF11502 | |
| Domain | Bcl-9 | 6.47e-06 | 2 | 48 | 2 | IPR015668 | |
| Domain | Aden_trnslctor | 4.99e-05 | 28 | 48 | 3 | IPR002113 | |
| Domain | Mit_carrier | 7.50e-05 | 32 | 48 | 3 | IPR002067 | |
| Domain | Na_trans_cytopl | 9.64e-05 | 6 | 48 | 2 | PF11933 | |
| Domain | Na_trans_cytopl | 9.64e-05 | 6 | 48 | 2 | IPR024583 | |
| Domain | Na_channel_asu | 2.87e-04 | 10 | 48 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 2.87e-04 | 10 | 48 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 2.87e-04 | 10 | 48 | 2 | PF06512 | |
| Domain | SOLCAR | 3.41e-04 | 53 | 48 | 3 | PS50920 | |
| Domain | - | 3.41e-04 | 53 | 48 | 3 | 1.50.40.10 | |
| Domain | Mitochondrial_sb/sol_carrier | 3.41e-04 | 53 | 48 | 3 | IPR018108 | |
| Domain | Mito_carr | 3.41e-04 | 53 | 48 | 3 | PF00153 | |
| Domain | Mt_carrier_dom | 3.41e-04 | 53 | 48 | 3 | IPR023395 | |
| Domain | EF-hand-dom_pair | 8.25e-04 | 287 | 48 | 5 | IPR011992 | |
| Domain | EF_HAND_2 | 2.90e-03 | 231 | 48 | 4 | PS50222 | |
| Domain | EF_hand_dom | 2.94e-03 | 232 | 48 | 4 | IPR002048 | |
| Domain | - | 4.48e-03 | 261 | 48 | 4 | 1.10.238.10 | |
| Domain | PH | 5.59e-03 | 278 | 48 | 4 | SM00233 | |
| Domain | PH_DOMAIN | 5.66e-03 | 279 | 48 | 4 | PS50003 | |
| Domain | PH_domain | 5.73e-03 | 280 | 48 | 4 | IPR001849 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01006 | 1.97e-06 | 10 | 37 | 3 | M47694 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE | 3.60e-06 | 12 | 37 | 3 | M27728 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 4.68e-06 | 13 | 37 | 3 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 4.68e-06 | 13 | 37 | 3 | M47751 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 4.68e-06 | 13 | 37 | 3 | M47703 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 5.94e-06 | 14 | 37 | 3 | M47692 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_TRANSPORT_OF_CALCIUM | 7.41e-06 | 15 | 37 | 3 | M47691 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 9.10e-06 | 16 | 37 | 3 | M47695 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_TRANSPORT_OF_CALCIUM | 1.32e-05 | 18 | 37 | 3 | M47761 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABBERANT_ATXN2_3_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.32e-05 | 18 | 37 | 3 | M47659 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TRANSPORT_OF_CALCIUM | 1.57e-05 | 19 | 37 | 3 | M47677 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.57e-05 | 19 | 37 | 3 | M47760 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 1.84e-05 | 20 | 37 | 3 | M47688 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 2.14e-05 | 21 | 37 | 3 | M47689 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.48e-05 | 22 | 37 | 3 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.48e-05 | 22 | 37 | 3 | M47675 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.84e-05 | 23 | 37 | 3 | M47676 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 2.84e-05 | 23 | 37 | 3 | M47666 | |
| Pathway | KEGG_HUNTINGTONS_DISEASE | 1.06e-04 | 182 | 37 | 5 | M13486 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 1.22e-04 | 37 | 37 | 3 | M1029 | |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 1.91e-04 | 43 | 37 | 3 | M881 | |
| Pathway | BIOCARTA_ETC_PATHWAY | 2.98e-04 | 10 | 37 | 2 | M15371 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE | 3.63e-04 | 11 | 37 | 2 | MM15471 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 2.09e-03 | 26 | 37 | 2 | MM14793 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 2.26e-03 | 27 | 37 | 2 | M27422 | |
| Pathway | WP_DRAVET_SYNDROME | 2.43e-03 | 28 | 37 | 2 | M45519 | |
| Pathway | WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA | 2.60e-03 | 105 | 37 | 3 | M39417 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 2.78e-03 | 30 | 37 | 2 | MM15170 | |
| Pathway | REACTOME_DRUG_ADME | 2.89e-03 | 109 | 37 | 3 | M45012 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 2.97e-03 | 31 | 37 | 2 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 3.16e-03 | 32 | 37 | 2 | M27455 | |
| Pathway | PID_EPHA_FWDPATHWAY | 3.57e-03 | 34 | 37 | 2 | M177 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 3.57e-03 | 34 | 37 | 2 | MM15025 | |
| Pubmed | DNA sequences of two expressed nuclear genes for human mitochondrial ADP/ATP translocase. | 2.63e-09 | 3 | 49 | 3 | 2541251 | |
| Pubmed | Two distinct genes for ADP/ATP translocase are expressed at the mRNA level in adult human liver. | 2.63e-09 | 3 | 49 | 3 | 2829183 | |
| Pubmed | 2.63e-09 | 3 | 49 | 3 | 12450408 | ||
| Pubmed | 1.05e-08 | 4 | 49 | 3 | 33396658 | ||
| Pubmed | 5.24e-08 | 6 | 49 | 3 | 10620603 | ||
| Pubmed | 6.29e-08 | 73 | 49 | 5 | 23464991 | ||
| Pubmed | 9.16e-08 | 7 | 49 | 3 | 21370995 | ||
| Pubmed | 1.46e-07 | 8 | 49 | 3 | 27641616 | ||
| Pubmed | Transglutaminase Type 2 Regulates ER-Mitochondria Contact Sites by Interacting with GRP75. | 3.13e-07 | 10 | 49 | 3 | 30590033 | |
| Pubmed | 5.73e-07 | 12 | 49 | 3 | 16120388 | ||
| Pubmed | 8.24e-07 | 122 | 49 | 5 | 29530978 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 1.67e-06 | 807 | 49 | 9 | 30575818 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 27048932 | ||
| Pubmed | Role of adenine nucleotide translocator 1 in mtDNA maintenance. | 1.94e-06 | 2 | 49 | 2 | 10926541 | |
| Pubmed | Sodium channel expression within chronic multiple sclerosis plaques. | 1.94e-06 | 2 | 49 | 2 | 17805013 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 16556444 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 2823266 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 35348308 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 10520747 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 15760941 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 20682801 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 18601978 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 38811552 | ||
| Pubmed | Expression and sequence analysis of the mouse adenine nucleotide translocase 1 and 2 genes. | 1.94e-06 | 2 | 49 | 2 | 10974536 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 33767438 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 19644512 | ||
| Pubmed | FGF14 N-terminal splice variants differentially modulate Nav1.2 and Nav1.6-encoded sodium channels. | 1.94e-06 | 2 | 49 | 2 | 19465131 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 26842067 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 15371335 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 12112115 | ||
| Pubmed | The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. | 1.94e-06 | 2 | 49 | 2 | 14749836 | |
| Pubmed | Block of a subset of sodium channels exacerbates experimental autoimmune encephalomyelitis. | 1.94e-06 | 2 | 49 | 2 | 23735284 | |
| Pubmed | A novel missense adenine nucleotide translocator-1 gene mutation in a Greek adPEO family. | 1.94e-06 | 2 | 49 | 2 | 11756613 | |
| Pubmed | Identification of the Mitochondrial Heme Metabolism Complex. | 3.43e-06 | 21 | 49 | 3 | 26287972 | |
| Pubmed | Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson's disease. | 5.21e-06 | 24 | 49 | 3 | 24725412 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 34545187 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 16831128 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 17928448 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 33649334 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 38514708 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 20637214 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 32845893 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 16033895 | ||
| Pubmed | Role of sodium channel subtype in action potential generation by neocortical pyramidal neurons. | 5.83e-06 | 3 | 49 | 2 | 29991598 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 28518218 | ||
| Pubmed | Ski regulates Hippo and TAZ signaling to suppress breast cancer progression. | 6.17e-06 | 84 | 49 | 4 | 25670202 | |
| Pubmed | A targeted deleterious allele of the splicing factor SCNM1 in the mouse. | 1.16e-05 | 4 | 49 | 2 | 18791226 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 17537961 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 35031483 | ||
| Pubmed | Rapid evolution of human pseudoautosomal genes and their mouse homologs. | 1.16e-05 | 4 | 49 | 2 | 8903724 | |
| Pubmed | Human-Specific ARHGAP11B Acts in Mitochondria to Expand Neocortical Progenitors by Glutaminolysis. | 1.16e-05 | 4 | 49 | 2 | 31883789 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 29578003 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 22423112 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 7983737 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 21156207 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 19699733 | ||
| Pubmed | Inhibition of mitochondrial permeability transition by deletion of the ANT family and CypD. | 1.16e-05 | 4 | 49 | 2 | 31489369 | |
| Pubmed | The ADP/ATP translocase drives mitophagy independent of nucleotide exchange. | 1.16e-05 | 4 | 49 | 2 | 31618756 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 11287411 | ||
| Pubmed | Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in FAP mouse models. | 1.94e-05 | 5 | 49 | 2 | 30760710 | |
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 24077057 | ||
| Pubmed | Vav family GEFs link activated Ephs to endocytosis and axon guidance. | 1.94e-05 | 5 | 49 | 2 | 15848800 | |
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 17052462 | ||
| Pubmed | LATS2 suppresses oncogenic Wnt signaling by disrupting β-catenin/BCL9 interaction. | 1.94e-05 | 5 | 49 | 2 | 24360964 | |
| Pubmed | TBX3 acts as tissue-specific component of the Wnt/β-catenin transcriptional complex. | 1.94e-05 | 5 | 49 | 2 | 32808927 | |
| Pubmed | H+ transport is an integral function of the mitochondrial ADP/ATP carrier. | 1.94e-05 | 5 | 49 | 2 | 31341297 | |
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 19328798 | ||
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 17724025 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | 2.23e-05 | 847 | 49 | 8 | 35235311 | |
| Pubmed | Next-generation sequencing to generate interactome datasets. | 2.80e-05 | 1147 | 49 | 9 | 21516116 | |
| Pubmed | Loss of BCL9/9l suppresses Wnt driven tumourigenesis in models that recapitulate human cancer. | 2.91e-05 | 6 | 49 | 2 | 30760720 | |
| Pubmed | 2.91e-05 | 6 | 49 | 2 | 17113272 | ||
| Pubmed | 2.91e-05 | 6 | 49 | 2 | 15574752 | ||
| Pubmed | Pax6-dependent, but β-catenin-independent, function of Bcl9 proteins in mouse lens development. | 2.91e-05 | 6 | 49 | 2 | 25184676 | |
| Pubmed | ANT-dependent MPTP underlies necrotic myofiber death in muscular dystrophy. | 2.91e-05 | 6 | 49 | 2 | 37624892 | |
| Pubmed | Are voltage-dependent ion channels involved in the endothelial cell control of vasomotor tone? | 2.91e-05 | 6 | 49 | 2 | 17513486 | |
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 2.91e-05 | 6 | 49 | 2 | 23652591 | |
| Pubmed | Regulation of insulin secretion by SIRT4, a mitochondrial ADP-ribosyltransferase. | 2.91e-05 | 6 | 49 | 2 | 17715127 | |
| Pubmed | 3.45e-05 | 653 | 49 | 7 | 33742100 | ||
| Pubmed | 4.07e-05 | 7 | 49 | 2 | 30366904 | ||
| Pubmed | Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. | 4.07e-05 | 7 | 49 | 2 | 25818041 | |
| Pubmed | Constitutive scaffolding of multiple Wnt enhanceosome components by Legless/BCL9. | 5.42e-05 | 8 | 49 | 2 | 28296634 | |
| Pubmed | 5.45e-05 | 146 | 49 | 4 | 29509794 | ||
| Pubmed | The mitochondrial transporter family SLC25: identification, properties and physiopathology. | 5.86e-05 | 53 | 49 | 3 | 23266187 | |
| Pubmed | 5.90e-05 | 711 | 49 | 7 | 33022573 | ||
| Pubmed | 5.93e-05 | 484 | 49 | 6 | 31995728 | ||
| Pubmed | 6.96e-05 | 9 | 49 | 2 | 15746173 | ||
| Pubmed | 6.96e-05 | 9 | 49 | 2 | 27218139 | ||
| Pubmed | 6.96e-05 | 9 | 49 | 2 | 16382098 | ||
| Pubmed | 8.16e-05 | 162 | 49 | 4 | 25796446 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 8.20e-05 | 1318 | 49 | 9 | 30463901 | |
| Pubmed | Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma. | 9.96e-05 | 329 | 49 | 5 | 34316702 | |
| Pubmed | 1.03e-04 | 64 | 49 | 3 | 22865885 | ||
| Pubmed | 1.05e-04 | 173 | 49 | 4 | 23979707 | ||
| Pubmed | Rearrangement of the Protein Phosphatase 1 Interactome During Heart Failure Progression. | 1.08e-04 | 174 | 49 | 4 | 29669786 | |
| Pubmed | Identification of novel Smad2 and Smad3 associated proteins in response to TGF-beta1. | 1.08e-04 | 65 | 49 | 3 | 18729074 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | 1.08e-04 | 1367 | 49 | 9 | 32687490 | |
| Pubmed | 1.10e-04 | 786 | 49 | 7 | 29128334 | ||
| Pubmed | 1.26e-04 | 803 | 49 | 7 | 36517590 | ||
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 1.27e-04 | 12 | 49 | 2 | 30175250 | |
| Interaction | CLN3 interactions | 7.02e-06 | 115 | 47 | 5 | int:CLN3 | |
| Interaction | SPRED1 interactions | 7.54e-06 | 54 | 47 | 4 | int:SPRED1 | |
| Interaction | SLC25A31 interactions | 1.15e-05 | 60 | 47 | 4 | int:SLC25A31 | |
| Interaction | SLC25A24 interactions | 1.53e-05 | 135 | 47 | 5 | int:SLC25A24 | |
| Interaction | ACRBP interactions | 1.77e-05 | 22 | 47 | 3 | int:ACRBP | |
| Interaction | OSTM1 interactions | 3.61e-05 | 80 | 47 | 4 | int:OSTM1 | |
| Interaction | COQ2 interactions | 6.79e-05 | 94 | 47 | 4 | int:COQ2 | |
| Interaction | LRRC25 interactions | 6.93e-05 | 185 | 47 | 5 | int:LRRC25 | |
| Interaction | PSMB10 interactions | 7.37e-05 | 96 | 47 | 4 | int:PSMB10 | |
| Interaction | SPRY3 interactions | 7.38e-05 | 35 | 47 | 3 | int:SPRY3 | |
| Interaction | ZEB1 interactions | 1.00e-04 | 200 | 47 | 5 | int:ZEB1 | |
| Interaction | RBM47 interactions | 1.10e-04 | 204 | 47 | 5 | int:RBM47 | |
| Interaction | SCN4B interactions | 1.48e-04 | 8 | 47 | 2 | int:SCN4B | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.45e-04 | 9 | 37 | 2 | 1203 | |
| GeneFamily | EF-hand domain containing | 1.01e-03 | 219 | 37 | 4 | 863 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CELF4 VSNL1 THEM4 SCN2A SCN8A GRIK3 ZMIZ1 HPCAL4 VAV2 TBC1D9 | 1.75e-05 | 1106 | 46 | 10 | M39071 |
| Coexpression | GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_UP | 1.89e-05 | 187 | 46 | 5 | M3287 | |
| Coexpression | GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_DN | 2.43e-05 | 197 | 46 | 5 | M4436 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-08 | 187 | 47 | 6 | 7b2cd0c618ed081223343f3bec2244c8723c9a31 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-06 | 180 | 47 | 5 | f6a2208960d0df1500c974cc44c3c054cd7475a9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-06 | 184 | 47 | 5 | 7d9bcdaff8cbea4c50ab7db0f8e01f6bbd0ef593 | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.52e-06 | 186 | 47 | 5 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-06 | 186 | 47 | 5 | d6c8ce2a32c218dcc63d861cc247152430ed3c8c | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.61e-06 | 188 | 47 | 5 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer-37|World / Primary Cells by Cluster | 2.02e-06 | 197 | 47 | 5 | 00d756bc0231e1b3b88430214338c1059cb11106 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.07e-06 | 198 | 47 | 5 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Basal-basal-2|World / Class top | 2.12e-06 | 199 | 47 | 5 | a728d8675d01f1b3143f06adfceca74d17f58477 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-05 | 171 | 47 | 4 | 99176a932569fa1c7e1c01009684f5a65244b96e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-05 | 177 | 47 | 4 | dc846d0feb94d4c289553cc3ac9dac81d10409cb | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.78e-05 | 179 | 47 | 4 | 228d12ed1c8dc92aefbcea4aaf7d108783c22be0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-05 | 185 | 47 | 4 | c083a4974590b9ed3ecafedd3e9cdebc5047fe39 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.39e-05 | 186 | 47 | 4 | d1d01ce46e62944aa9864eda47e8401b5f0d2bdc | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-05 | 187 | 47 | 4 | 1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41 | |
| ToppCell | (1)_T_CD4_naive|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 4.58e-05 | 188 | 47 | 4 | b8f67ac2faadd5b848955e43ab5d6cf5e49b3681 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-05 | 189 | 47 | 4 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 4.77e-05 | 190 | 47 | 4 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.77e-05 | 190 | 47 | 4 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | Healthy_Control-Lymphoid-T-CCR7+_T|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.97e-05 | 192 | 47 | 4 | 5b197f65a87c315e4f50c77a7fdec3b342a863ad | |
| ToppCell | Posterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.07e-05 | 193 | 47 | 4 | b4989e3436e84dbec3789b46057e0f7a0ebf09d4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.07e-05 | 193 | 47 | 4 | 5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.07e-05 | 193 | 47 | 4 | 194b49c152e3e3f599068ec88a7f0af6427b743a | |
| ToppCell | T_cells-Central_memory_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 5.07e-05 | 193 | 47 | 4 | 725326d7e3604736b607c19f4069c81cb4f2d20c | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.17e-05 | 194 | 47 | 4 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-CFuPNs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 5.27e-05 | 195 | 47 | 4 | 574354ef4bcefeb9856b65d19bb92e2cffe5dc7a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid|BALF-PFMC / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.38e-05 | 196 | 47 | 4 | 6361c37b0292ba9e5bf485a4809d2b0cd894c26e | |
| ToppCell | primary_visual_cortex-Neuronal|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.38e-05 | 196 | 47 | 4 | 8efc2b3a95f57c31be203ac781b2098d4909297f | |
| ToppCell | frontal_cortex-Neuronal|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.38e-05 | 196 | 47 | 4 | de7d10da862f98894ce47244fbc992f4a12d63bb | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.38e-05 | 196 | 47 | 4 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Neuronal-CPNs|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 5.38e-05 | 196 | 47 | 4 | c9e7ac34993c873de4f198cdae77dcf099731532 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 5.49e-05 | 197 | 47 | 4 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 5.49e-05 | 197 | 47 | 4 | 4961f66606f08e399508fd6cabca588e7ab406a8 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 5.49e-05 | 197 | 47 | 4 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | distal-Hematologic-CD4+_Naive_T-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.60e-05 | 198 | 47 | 4 | 4db9eff17778ffc3f77c017ff64f55bc1626da24 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.60e-05 | 198 | 47 | 4 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.60e-05 | 198 | 47 | 4 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.60e-05 | 198 | 47 | 4 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | BLOOD--(3)_MNP-(3)_Intermediate_monocytes|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.60e-05 | 198 | 47 | 4 | 70c3efd4f6026a6a6065be632160a265d9ecd1e4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.60e-05 | 198 | 47 | 4 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 5.71e-05 | 199 | 47 | 4 | 0cd3e4e0fba000c996feaf012ff32198e1048c9d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.82e-05 | 200 | 47 | 4 | 2f481e2fd248c02a5aa2e0248c16808df142fed2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.82e-05 | 200 | 47 | 4 | dc674124475edf83908b51a4e1454bc2dc4f06fa | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.82e-05 | 200 | 47 | 4 | bd4b9f6b37f4a3c960c4149cf0cfd2caf3327d2d | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 5.82e-05 | 200 | 47 | 4 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Intermediate|3m / Sample Type, Dataset, Time_group, and Cell type. | 5.82e-05 | 200 | 47 | 4 | cbd0b9188a94778ffa539912aeb2a4378f0ab88f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.82e-05 | 200 | 47 | 4 | 87c453bb3fa35fff6417dce1f9b08a335fd1546d | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Interneuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 5.82e-05 | 200 | 47 | 4 | f5c63ef52bd7a898cf009b8bf9b2f7f4890d1c9b | |
| Drug | Clodronate | 8.24e-09 | 3 | 47 | 3 | DB00720 | |
| Drug | dehydroabietylamine | 3.29e-08 | 4 | 47 | 3 | ctd:C000600819 | |
| Drug | closantel | 2.87e-07 | 7 | 47 | 3 | ctd:C023342 | |
| Drug | AC1L4X2K | 9.79e-07 | 10 | 47 | 3 | CID000193824 | |
| Drug | oleoylcarnitine | 4.53e-06 | 16 | 47 | 3 | CID006441392 | |
| Drug | beta-hydroxypalmitoyl-CoA | 5.49e-06 | 17 | 47 | 3 | CID000440600 | |
| Drug | phosphocreatine disodium | 6.10e-06 | 126 | 47 | 5 | CID000000587 | |
| Drug | agaric acid | 9.17e-06 | 20 | 47 | 3 | CID000012629 | |
| Drug | AC1L193Y | 9.84e-06 | 65 | 47 | 4 | CID000000380 | |
| Drug | phenylsuccinate | 1.07e-05 | 21 | 47 | 3 | CID000095459 | |
| Drug | asebotoxin III | 1.25e-05 | 3 | 47 | 2 | CID000115156 | |
| Drug | carboxyatractyloside | 1.25e-05 | 3 | 47 | 2 | ctd:C003853 | |
| Drug | octogen | 2.07e-05 | 26 | 47 | 3 | CID000017596 | |
| Drug | 3,5-DBSF | 2.50e-05 | 4 | 47 | 2 | CID006438567 | |
| Drug | APETx2 protein, Anthopleura elegantissima | 2.50e-05 | 4 | 47 | 2 | ctd:C501880 | |
| Drug | HCOH (hydroxymethylene) | 3.56e-05 | 31 | 47 | 3 | CID006432217 | |
| Drug | 2,4-dinitrophenol | 3.58e-05 | 90 | 47 | 4 | CID000001493 | |
| Drug | AC1L2A54 | 4.54e-05 | 191 | 47 | 5 | CID000068636 | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 5.01e-05 | 195 | 47 | 5 | 3862_UP | |
| Drug | APETx1, Anthopleura elegantissima | 6.22e-05 | 6 | 47 | 2 | ctd:C475726 | |
| Drug | Bongkrekic Acid | 6.22e-05 | 6 | 47 | 2 | ctd:D001865 | |
| Drug | calcein | 6.22e-05 | 6 | 47 | 2 | CID000065079 | |
| Drug | desflurane | 7.72e-05 | 40 | 47 | 3 | CID000042113 | |
| Drug | racephenicol | 7.72e-05 | 40 | 47 | 3 | CID000005433 | |
| Drug | fluorocyclobutane | 8.70e-05 | 7 | 47 | 2 | CID011051569 | |
| Drug | nimesulide | 9.01e-05 | 114 | 47 | 4 | CID000004495 | |
| Drug | hexadecanal | 1.01e-04 | 226 | 47 | 5 | CID000000984 | |
| Drug | sanglifehrin A | 1.03e-04 | 44 | 47 | 3 | CID005388925 | |
| Drug | oleoyl coenzyme A | 1.03e-04 | 118 | 47 | 4 | CID000000966 | |
| Drug | 2,3,5,6-tetrafluoro-4-methylbenzyl (Z)-(1RS)-cis-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate | 1.16e-04 | 8 | 47 | 2 | ctd:C489827 | |
| Drug | CID5288005 | 1.34e-04 | 48 | 47 | 3 | CID005288004 | |
| Drug | Methylphenidate | 1.45e-04 | 129 | 47 | 4 | ctd:D008774 | |
| Drug | benzo(F)quinoxaline | 1.49e-04 | 9 | 47 | 2 | CID000098494 | |
| Disease | autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2 (implicated_via_orthology) | 1.42e-08 | 4 | 46 | 3 | DOID:0111517 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | 6.70e-07 | 477 | 46 | 8 | C0005586 | |
| Disease | epilepsy (implicated_via_orthology) | 5.52e-06 | 163 | 46 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Benign familial infantile epilepsy | 7.13e-06 | 3 | 46 | 2 | cv:C5575231 | |
| Disease | hypertrophic cardiomyopathy (implicated_via_orthology) | 1.26e-05 | 29 | 46 | 3 | DOID:11984 (implicated_via_orthology) | |
| Disease | Psychotic Disorders | 1.89e-05 | 101 | 46 | 4 | C0033975 | |
| Disease | mitochondrial metabolism disease (implicated_via_orthology) | 2.24e-05 | 35 | 46 | 3 | DOID:700 (implicated_via_orthology) | |
| Disease | Familial benign neonatal epilepsy | 3.55e-05 | 6 | 46 | 2 | C0220669 | |
| Disease | Colorectal Carcinoma | 1.00e-04 | 702 | 46 | 7 | C0009402 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.06e-04 | 10 | 46 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.06e-04 | 10 | 46 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.55e-04 | 12 | 46 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | rostral anterior cingulate cortex volume measurement | 1.83e-04 | 13 | 46 | 2 | EFO_0010327 | |
| Disease | Schizophrenia | 4.06e-04 | 883 | 46 | 7 | C0036341 | |
| Disease | hair color | 1.39e-03 | 311 | 46 | 4 | EFO_0003924 | |
| Disease | cataract | 1.39e-03 | 141 | 46 | 3 | MONDO_0005129 | |
| Disease | mitochondrial DNA measurement | 1.69e-03 | 328 | 46 | 4 | EFO_0006312 | |
| Disease | guilt measurement | 1.79e-03 | 40 | 46 | 2 | EFO_0009595 | |
| Disease | Celiac Disease | 2.46e-03 | 47 | 46 | 2 | C0007570 | |
| Disease | TPE interval measurement | 3.00e-03 | 52 | 46 | 2 | EFO_0004644 | |
| Disease | ecosanoids measurement | 3.35e-03 | 55 | 46 | 2 | EFO_0020044 | |
| Disease | lymphocyte percentage of leukocytes | 3.66e-03 | 665 | 46 | 5 | EFO_0007993 | |
| Disease | information processing speed, response to cranial radiation therapy | 3.72e-03 | 58 | 46 | 2 | EFO_0004363, EFO_0010950 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RRMMMQSGRKGADIM | 236 | P12236 | |
| MMMIIIRVAAGMRPS | 231 | Q8NFD2 | |
| RRMMMQSGRKGTDIM | 236 | P05141 | |
| AEMVMGGMVLETNMN | 121 | Q92572 | |
| AMILLGNVGMMTIIM | 61 | Q8NGE7 | |
| MPMERQMSVNSSIMG | 196 | Q02930 | |
| MVGTVIMMRMNQDGL | 131 | Q9UM19 | |
| MMCLQDKGLVVAQMM | 111 | Q92604 | |
| VYLMMNNQMRLLGME | 346 | P06681 | |
| EQNMAKMRLLTFMGM | 271 | Q7L2H7 | |
| MMLPLQGAQMLQMLE | 1 | Q6IB77 | |
| RMGLVMDRMGSVERM | 436 | P52272 | |
| AMRTQMQQMHGRMVP | 971 | P54764 | |
| MMLIVNMVQGSFMAT | 436 | Q49A26 | |
| MSQAMIRGMMDEEGN | 241 | Q8N7H5 | |
| MGGAMHKAMLMAQAI | 516 | Q9YNA8 | |
| GGAMHKAMLMAQAMR | 516 | Q9HDB9 | |
| MGGAMHKAMLMAQAI | 516 | P62684 | |
| IMTRGMMFVNMTPCQ | 151 | Q9NZD1 | |
| GMAMEGIRPSMEMNR | 646 | O00512 | |
| DMGQQMNMMIQRLGQ | 496 | Q86UU0 | |
| TMAAQILKQAMAMGM | 236 | Q13003 | |
| GAMEIVAMDMKLRGM | 516 | A3KN83 | |
| GFNTRSANGMLMNMM | 156 | Q66K64 | |
| AVMVLMVPVNAVMAM | 471 | P33527 | |
| AMGMQMRKAIMIEVD | 521 | Q96J94 | |
| QVPMNMTITGCMMTF | 96 | Q9H9B4 | |
| QMGSERMEMRKRQMP | 171 | O76081 | |
| MMNMARLNRTAAGLM | 241 | P49903 | |
| VTFMAMVLMQMGQPA | 486 | Q8IUH8 | |
| MIRQGGNTLMVKVVM | 741 | Q9Y566 | |
| RRMMMQSGRKGADIM | 236 | P12235 | |
| RTMRRMQQMAGQMGM | 236 | Q9BZC1 | |
| TGMAMRIRVGQSMNM | 471 | P21980 | |
| MVGTVIMMKMNEDGL | 131 | P62760 | |
| SMMGVPNGMMTTQQA | 346 | Q8WU79 | |
| MCAMMAGGIVMTANL | 166 | Q5T1C6 | |
| LVERCMGAMQEGMQM | 41 | O75038 | |
| MGAMQEGMQMVKLRG | 46 | O75038 | |
| IMRGTPQIQRVMTMM | 331 | P42331 | |
| MVGEMTMVNVGMNDQ | 331 | Q7Z6L1 | |
| MMARITSAKNIRMMG | 1236 | Q6ZT07 | |
| LVIMVRTVQGMAQGM | 146 | O00624 | |
| QTMCLTVFMMVMVIG | 956 | Q99250 | |
| AMCLIVFMMVMVIGN | 951 | Q9UQD0 | |
| QDVDMMDQNGMTPLM | 181 | Q8IUH5 | |
| VYGNMGITKMNMNVM | 836 | Q96AY4 | |
| LALQGTQGQEKMMMM | 11 | Q9UNY5 | |
| IARMQAQMQMQMQGG | 336 | Q15019 | |
| QQPMIRYMQKMGMTE | 181 | P52735 | |
| SQMIMPNVMEMIAAL | 851 | Q9ULJ6 |